This is a convergence of multi-disciplinary talents across the nations, together with the collaboration among industry, academic, research institutes, and the power of innovation. We are actively engaging collaboration and interaction with major multinational biotech companies, and incorporate world class advanced diagnosis platform. Our objective is to synchronize molecular diagnosis technology in Taiwan with the advanced nations around the world. Taking foothold in Taiwan, we dedicated ourselves to major fields in diagnosis and prevention of cancers.

Synergy with the professional resource and service chain from parent company -Healthconn. Based on individual unique gene, environment and life style to decipher digital code, then further develop precision and personalized medical standard. Integrate resources to provide following services in accordance with customer demand: Technology development, clinical trial, health management, plus early prevention and diagnosis of cancer. Provide a comprehensive service to satisfy customer demand.